<!doctype html>
<html lang="en">
  <head>
    <link rel="canonical" href="https://neweramabs.com" />
    <meta charset="UTF-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=edge" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Innovative Antibody Solutions | 4x Faster Antibody Discovery with new/era/mabs</title>

    <!-- Meta SEO -->
    <meta name="title" content="Innovative Antibody Solutions | 4x Faster Antibody Discovery with new/era/mabs" />
    <meta
      name="description"
      content="Discover groundbreaking antibody solutions with new/era/mabs. Our scalable platform accelerates antibody discovery and manufacturing across murine, human, and camelid sources, delivering results four times faster than conventional methods. Partner with us for tailored, rapid, and infinite screening options, ensuring precise diagnostics and therapeutics for future pandemics and diverse research needs."
    />
    <meta name="robots" content="index, follow" />
    <meta name="language" content="English" />
    <meta name="author" content="new/era/mabs" />

    <!-- Social Media Share -->
    <meta property="og:title" content="Innovative Antibody Solutions | 4x Faster Antibody Discovery with new/era/mabs" />
    <meta property="og:site_name" content="new/era/mabs" />
    <meta property="og:url" content="https://neweramabs.com" />
    <meta
      property="og:description"
      content="Discover groundbreaking antibody solutions with new/era/mabs. Our scalable platform accelerates antibody discovery and manufacturing across murine, human, and camelid sources, delivering results four times faster than conventional methods. Partner with us for tailored, rapid, and infinite screening options, ensuring precise diagnostics and therapeutics for future pandemics and diverse research needs."
    />
    <meta property="og:type" content="website" />
    <!-- <meta property="og:image" content="https://neweramabs.com/assets/nem-selma.jpg" /> -->

    <!-- Favicon -->
    <!-- `sizes="any"` is to fix Chrome bug -->
    <link rel="icon" href="/favicon.ico" sizes="any" />
    <link rel="icon" href="/icon.svg" type="image/svg+xml" />
    <link rel="apple-touch-icon" href="/apple-touch-icon.png" />
    <link rel="manifest" href="/manifest.webmanifest" />

    <link href="css/nem.css" rel="stylesheet" />
    <script async defer src="https://buttons.github.io/buttons.js"></script>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.5.2/css/all.min.css" />
  </head>
  <body>
    <header class="fixed z-50 w-full">
      <nav class="border-gray-200 bg-white py-2.5">
        <div class="mx-auto flex max-w-screen-xl flex-wrap items-center justify-between px-4">
          <a href="/" class="flex items-center">
            <img src="assets/nem-logo.svg" class="mr-3 h-6 sm:h-9" alt="new/era/mabs home" />
          </a>
          <div class="flex items-center lg:order-2">
            <a
              href="#"
              class="rounded-lg bg-nem-light px-4 py-2 text-sm font-medium text-nem-dark hover:bg-nem-300 focus:outline-none focus:ring-4 focus:ring-nem-300 sm:mr-2 lg:mr-0 lg:px-5 lg:py-2.5"
              >Contact Us</a
            >
            <button
              data-collapse-toggle="mobile-menu-2"
              type="button"
              class="ml-1 inline-flex items-center rounded-lg p-2 text-sm text-gray-500 hover:bg-gray-100 focus:outline-none focus:ring-2 focus:ring-gray-200 lg:hidden"
              aria-controls="mobile-menu-2"
              aria-expanded="false"
            >
              <span class="sr-only">Open main menu</span>
              <svg class="h-6 w-6" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                <path
                  fill-rule="evenodd"
                  d="M3 5a1 1 0 011-1h12a1 1 0 110 2H4a1 1 0 01-1-1zM3 10a1 1 0 011-1h12a1 1 0 110 2H4a1 1 0 01-1-1zM3 15a1 1 0 011-1h12a1 1 0 110 2H4a1 1 0 01-1-1z"
                  clip-rule="evenodd"
                ></path>
              </svg>
              <svg class="hidden h-6 w-6" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                <path
                  fill-rule="evenodd"
                  d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z"
                  clip-rule="evenodd"
                ></path>
              </svg>
            </button>
          </div>
          <div class="hidden w-full items-center justify-between lg:order-1 lg:flex lg:w-auto" id="mobile-menu-2">
            <ul class="mt-4 flex flex-col font-medium lg:mt-0 lg:flex-row lg:space-x-8">
              <li>
                <a href="science.html" class="lg: lg: block border-b border-gray-100 py-2 pl-3 pr-4 text-gray-700 hover:bg-gray-50 lg:border-0 lg:p-0 lg:hover:bg-transparent lg:hover:text-nem-500"
                  >Our Science</a
                >
              </li>
              <li>
                <a href="disease-x.html" class="lg: lg: block border-b border-gray-100 py-2 pl-3 pr-4 text-gray-700 hover:bg-gray-50 lg:border-0 lg:p-0 lg:hover:bg-transparent lg:hover:text-nem-500"
                  >Disease X</a
                >
              </li>
              <li>
                <a
                  href="#"
                  class="lg: lg: block border-b border-gray-100 py-2 pl-3 pr-4 text-nem-500 hover:bg-gray-50 lg:border-0 lg:p-0 lg:hover:bg-transparent lg:hover:text-nem-500"
                  aria-current="page"
                  >Service</a
                >
              </li>
              <li>
                <a href="products.html" class="lg: lg: block border-b border-gray-100 py-2 pl-3 pr-4 text-gray-700 hover:bg-gray-50 lg:border-0 lg:p-0 lg:hover:bg-transparent lg:hover:text-nem-500"
                  >Products</a
                >
              </li>
              <li>
                <a href="about.html" class="lg: lg: block border-b border-gray-100 py-2 pl-3 pr-4 text-gray-700 hover:bg-gray-50 lg:border-0 lg:p-0 lg:hover:bg-transparent lg:hover:text-nem-500"
                  >About Us</a
                >
              </li>
            </ul>
          </div>
        </div>
      </nav>
    </header>

    <!-- Start block -->
    <section class="bg-nem-100 pt-20 lg:pt-28">
      <div class="mx-auto grid max-w-screen-xl px-4 pb-8 lg:grid-cols-12 lg:gap-8 lg:py-16 xl:gap-0">
        <div class="relative z-20 mr-auto place-self-center lg:col-span-7">
          <h1 class="mb-4 max-w-2xl bg-gradient-to-r from-nem-dark to-nem-light bg-clip-text pb-3 text-4xl font-extrabold tracking-tight text-transparent md:text-5xl xl:text-6xl">
            Tailored Antibody Solutions: From Start to Finish.
          </h1>
          <p class="mb-6 max-w-2xl font-light text-gray-500 md:text-lg lg:mb-8 lg:text-xl">
            Expert support in antibody discovery, antigen-specific immortal cell pools, efficient screening, and versatile modifications to drive your research success.
          </p>
        </div>
        <div class="relative z-20 hidden lg:col-span-5 lg:mt-0 lg:flex">
          <div class="overflow-hidden rounded-3xl shadow-2xl shadow-nem-800">
            <!-- <img src="" alt="Hero Image" class="size-96 opacity-80" /> -->
          </div>
        </div>
      </div>
    </section>
    <!-- End block -->
    <!-- Start block -->
    <section class="bg-gray-50">
      <div class="mx-auto max-w-screen-xl space-y-12 px-4 py-8 lg:space-y-20 lg:px-6 lg:py-24">
        <!-- Row Text Left -->
        <div class="items-center gap-8 lg:grid lg:grid-cols-2 xl:gap-16">
          <div class="text-gray-500 sm:text-lg">
            <h2 class="mb-4 text-3xl font-extrabold tracking-tight text-gray-900">Customized Antibody Sets</h2>
            <p class="mb-8 font-light lg:text-xl">
              There are many paths to success. Therefore, it is crucial to have a large portfolio of available tools to explore these paths. For patient-focused therapies, this means having a large
              pool of potential antibodies from different origins right from the start to drive development optimally.
            </p>
            <!-- List -->
            <ul role="list" class="my-7 space-y-5 border-t border-gray-200 pt-8">
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">Camelid VHH or full-length heavy-chain only antibodies</span>
              </li>
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">Mouse monoclonal antibodies</span>
              </li>
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">Human monoclonal antibodies</span>
              </li>
            </ul>
            <p class="mb-8 font-light lg:text-xl">new/era/mabs provides small-scale sets of target-specific antibodies selected with selma to rapidly support your projects.</p>
          </div>
          <img class="mb-4 hidden w-full rounded-lg lg:mb-0 lg:flex" src="./images/feature-1.png" alt="dashboard feature image" />
        </div>
        <!-- Row Text Right-->
        <div class="items-center gap-8 lg:grid lg:grid-cols-2 xl:gap-16">
          <img class="mb-4 hidden w-full rounded-lg lg:mb-0 lg:flex" src="./images/feature-2.png" alt="feature image 2" />
          <div class="text-gray-500 sm:text-lg">
            <h2 class="mb-4 text-3xl font-extrabold tracking-tight text-gray-900">Antigen-specific immortal cell pools</h2>
            <p class="mb-8 font-light lg:text-xl">
              The ability to access target-specific cell pools and infinitely screen them using selma is another innovative feature that supports developments in patient-focused therapies. The
              iterative screening options allow immortal cell pools to target any desired antigen, enabling the identification of suitable new binders much faster and more effectively.
            </p>
            <!-- List -->
            <ul role="list" class="my-7 space-y-5 border-t border-gray-200 pt-8">
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">Accelerated screening of antigen-specific cell pools</span>
              </li>
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">Reusable and infinite screening options</span>
              </li>
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">Fast selection of novel binders</span>
              </li>
            </ul>
            <p class="font-light lg:text-xl">In particular, for targets with a high mutation rate, such as viruses, these pools represent a valuable resource for pandemic preparedness.</p>
          </div>
        </div>
        <!-- Row Text Left -->
        <div class="items-center gap-8 lg:grid lg:grid-cols-2 xl:gap-16">
          <div class="text-gray-500 sm:text-lg">
            <h2 class="mb-4 text-3xl font-extrabold tracking-tight text-gray-900">End-to-End Support</h2>
            <p class="mb-8 font-light lg:text-xl">
              new/era/mabs offers comprehensive solutions for all antibody-related inquiries, leveraging extensive and specialized expertise to achieve the targeted project goals.
            </p>
            <!-- List -->
            <ul role="list" class="my-7 space-y-5 border-t border-gray-200 pt-8">
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">In-house recombinant protein expression systems to create specific target variations</span>
              </li>
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900"
                  >AI based in silico modeling to identify suitable epitopes and incorporation of them in viral immunocarriers for a targeted immunization approach</span
                >
              </li>
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">Leveraging different selma setups for different antibody isotypes, cross-reactivities and affinities</span>
              </li>
            </ul>
            <p class="mb-8 font-light lg:text-xl">
              The team comprises experienced scientists who understand the biology behind each project and develop corresponding strategies to reach the desired outcomes.
            </p>
          </div>
          <img class="mb-4 hidden w-full rounded-lg lg:mb-0 lg:flex" src="./images/feature-1.png" alt="dashboard feature image" />
        </div>
        <!-- Row Text Right-->
        <div class="items-center gap-8 lg:grid lg:grid-cols-2 xl:gap-16">
          <img class="mb-4 hidden w-full rounded-lg lg:mb-0 lg:flex" src="./images/feature-2.png" alt="feature image 2" />
          <div class="text-gray-500 sm:text-lg">
            <h2 class="mb-4 text-3xl font-extrabold tracking-tight text-gray-900">Versatile Modifications</h2>
            <p class="mb-8 font-light lg:text-xl">
              Downstream modifications of antibodies to enable customized antibody formats is a mandatory requirement for targeted therapies. new/era/mabs provides capabilities to modify selected
              antibodies with desired tags, fluorescence and enzyme labelings, and different antibody formats.
            </p>
            <ul role="list" class="my-7 space-y-5 border-t border-gray-200 pt-8">
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">Expression of antibodies with site-directed biotinylation</span>
              </li>
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">Chimeric antibodies with different combinations of Fc parts</span>
              </li>
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">Diabodies or Bispecifics </span>
              </li>
            </ul>
          </div>
        </div>
        <!-- Row Text Left -->
        <div class="items-center gap-8 lg:grid lg:grid-cols-2 xl:gap-16">
          <div class="text-gray-500 sm:text-lg">
            <h2 class="mb-4 text-3xl font-extrabold tracking-tight text-gray-900">Specialized Assay Development</h2>
            <p class="mb-8 font-light lg:text-xl">
              Depending on the final application, it is frequently necessary to develop specific assays or flow cytometry workflows to characterize and evaluate the binding properties of the obtained
              antibodies.
            </p>
            <ul role="list" class="my-7 space-y-5 border-t border-gray-200 pt-8">
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">Indirect, direct, and competitive immunoassays</span>
              </li>
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">Bead-based purifications or pull-down assays</span>
              </li>
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">Flow cytometric multi-staining panels and immunofluorescence setups</span>
              </li>
            </ul>
            <p class="font-light lg:text-xl">new/era/mabs establishes customized assay formats, flow cytometry workflows, and immunostainings to support the successful outcome of your projects.</p>
          </div>
        </div>
      </div>
    </section>
    <!-- End block -->

    <footer class="bg-white">
      <div class="mx-auto max-w-screen-xl p-4 py-6 md:p-8 lg:p-10 lg:py-16">
        <div class="flex flex-col justify-center space-y-8 md:flex-row md:space-x-40 md:space-y-0">
          <div>
            <h3 class="mb-6 text-sm font-semibold uppercase text-gray-900">Solutions</h3>
            <ul class="text-gray-500">
              <li class="mb-4">
                <a href="science.html" class="hover:underline">Our Science</a>
              </li>
              <li class="mb-4">
                <a href="disease-x.html" class="hover:underline">Disease X</a>
              </li>
              <li class="mb-4">
                <a href="service.html" class="hover:underline">Service</a>
              </li>
              <li class="mb-4">
                <a href="products.html" class="hover:underline">Products</a>
              </li>
            </ul>
          </div>
          <div>
            <h3 class="mb-6 text-sm font-semibold uppercase text-gray-900">Company</h3>
            <ul class="text-gray-500">
              <li class="mb-4">
                <a href="about.html" class="hover:underline">About</a>
              </li>
              <li class="mb-4">
                <a href="https://www.linkedin.com/company/neweramabs/" target="_blank" rel="noopener noreferrer" class="hover:underline">LinkedIn</a>
              </li>
            </ul>
          </div>
          <div>
            <h3 class="mb-6 text-sm font-semibold uppercase text-gray-900">Legal</h3>
            <ul class="text-gray-500">
              <li class="mb-4">
                <a href="privacy-policy.html" class="hover:underline">Privacy Policy</a>
              </li>
              <li class="mb-4">
                <a href="terms-and-conditions.html" class="hover:underline">Terms and Conditions</a>
              </li>
              <li class="mb-4">
                <a href="legal-disclosure.html" class="hover:underline">Legal Disclosure</a>
              </li>
            </ul>
          </div>
        </div>

        <hr class="my-6 border-gray-200 sm:mx-auto lg:my-8" />
        <div class="text-center">
          <a href="#" class="mb-5 flex items-center justify-center text-2xl font-semibold text-gray-900">
            <img src="assets/nem-logo.svg" class="mr-3 h-6 sm:h-9" alt="new/era/mabs Logo" />
          </a>
          <span class="block text-center text-sm text-gray-500"
            >© new/era/mabs GmbH. All Rights Reserved. Built with <a href="https://flowbite.com" class="text-nem-500 hover:underline">Flowbite</a>,
            <a href="https://tailwindcss.com" class="text-nem-500 hover:underline">Tailwind CSS</a>,

            <a href="https://fontawesome.com" class="text-nem-500 hover:underline">Font Awesome</a>, <a href="https://undraw.co/" class="text-nem-500 hover:underline">Undraw</a>, and
            <a href="https://storyset.com" class="text-nem-500 hover:underline">StorySet</a>.
          </span>
        </div>
      </div>
    </footer>
    <script type="module" src="main.js"></script>
  </body>
</html>
